100%
of patients in treatment group showed improved vision
MacuMira Treatment for Dry AMD
Seamless implementation. Full device support. Elevated care for your dry AMD patients.
.png?width=2250&height=2250&name=Your%20paragraph%20text%20(9).png)
Provide Your Patients With Improved Vision
Delivering a diagnosis of dry AMD to a patient is hard. Having few options to preserve and protect their vision means letting them leave your clinic without a true resolution.
With MacuMira, you finally have a solution. You can provide real help instead of just hope.
MacuMira is a unique medical device that uses precisely delivered microcurrent to stimulate retinal pigment epithelium (RPE) cells, enhancing mitochondrial activity to support cellular energy production and preserve or improve visual function in people living with dry AMD.
All MacuMira providers receive comprehensive staff training and support from the start and throughout the lifetime of their device.
The MacuMira Process
Training Your Team
One of our certified MacuMira trainers will visit you for a half-day of hands-on training. By the end of the day, your team will be ready to provide MacuMira treatment to patients.
Seamless Implementation
MacuMira is designed to integrate smoothly into your existing patient flow. With straightforward protocols and intuitive operation, your team can get up to speed quickly.
Microcurrent Stimulation
MacuMira uses Microcurrent Stimulation to support retinal health. It’s the first and only treatment of its kind for dry AMD, built on technology that has been safely used for decades.
Patented Waveform & Delivery
MacuMira’s patented Microcurrent Stimulation was developed to maximize therapeutic efficacy. Our intuitive user interface is straightforward for a technician to operate.
Retinal Rejuvenation
MacuMira’s stimulation of RPE cells enhances mitochondrial ATP formation, leading to improved cellular function.
Maintaining Results
Patients often have noticeable improvement in visual function after the initial 10-day loading phase (4 x 32-minute sessions). These improvements can be maintained with one treatment every 3 months.
Become a MacuMira Provider
Curious about the technology, the device cost, or how you can offer effective dry AMD treatment to your patients? Sign up and we’ll reach out promptly with information. Our mission is to bring innovation in dry AMD treatment.
MacuMira providers receive comprehensive training from our team to support your successful device implementation. Our mission is to improve the vision and quality of life of people around the world living with dry AMD, and we’d love your help.
MacuMira Clinical Trial
0%
rate of adverse effects
+8.2 Letters
in average ETDRS visual acuity improvements (25% increase) for treatment group
Contact us
Have questions or need assistance? Fill out the form below, and our team will get back to you shortly. We're here to help!
Frequently asked questions
How does MacuMira help with vision loss from dry AMD?
MacuMira delivers gentle microcurrent energy through your eyelids that stimulates the retina. This is designed to help support your visual function and slow the progression of dry AMD.
What is a MacuMira treatment session like?
Treatments take place at your MacuMira provider’s eye care office, with each session lasting about 32 minutes.
During the treatment, you will be seated or reclined while a headset is placed over your eyes.
Contoured eye cups rest gently on your closed eyelids, delivering microcurrent stimulation to the retina. Many patients find it relaxing enough to fall asleep during treatment.
Some patients experience a mild tingling sensation or brief patterns of light during the session. These are known as phosphenes and are a normal response to the stimulation.
After the session, you can continue with your day as normal with no downtime or restrictions.
Is MacuMira painful or invasive?
No, MacuMira treatment isn’t painful, and there are no needles or drugs involved. It’s completely noninvasive.
Some patients feel a slight tingling sensation during the session, but it’s generally very comfortable and well-tolerated.
Is MacuMira a cure for dry AMD?
Unfortunately, there is currently no cure for dry AMD. MacuMira is not a cure. However, it may help improve functional vision and slow progressive vision loss in people with dry AMD.
Is MacuMira safe?
Yes! MacuMira is a noninvasive treatment that has demonstrated a clinically proven strong safety profile. It has undergone rigorous safety review and licensing by Health Canada and meets the standards required of Class II medical devices.
The stimulation uses microcurrent levels that are incapable of causing muscle contraction and remain well below thresholds associated with discomfort or tissue damage.
No adverse events were reported in the prospective clinical study, and the treatment has now been used in clinical settings with excellent tolerability across thousands of treatment sessions.
Patients typically find the treatment comfortable and easy to complete. It doesn’t involve pills, lasers, injections, or any surgery.
How long do the benefits of dry AMD treatment last?
Many patients who receive MacuMira begin to notice improvements within the first 10 days during the initial loading phase of treatment.
To maintain those gains, follow-up treatments are typically recommended at least every 3 months. Your optometrist or ophthalmologist will determine the ideal schedule based on your condition and how your vision responds.
What other dry AMD treatments are available?
There are currently no other authorized treatments for dry AMD, and nothing else has been shown to improve vision lost to dry AMD.
After diagnosing early stage dry AMD, eye care providers typically recommend lifestyle changes such as healthy eating, quitting smoking, and regular exercise to potentially slow the progression of dry AMD.
For intermediate dry AMD, eye care providers typically recommend dietary supplements, such as AREDS or AREDS2 vitamins. These may slow the progression of the disease, but do not improve vision.